Renalytix offers KidneyIntelX, a risk assessment test for use in adult patients with type 2 diabetes and early-stage CKD (1-3). KidneyIntelX is based on an algorithm that utilizes biomarkers and clinical features to accurately identify the 1 in 5 patients who is at highest risk for kidney failure. Stop by Booth 1518 to learn more! www.kidneyintelx.com.